Skip to content

Author

J∅rgen Agnholt

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Dual Therapy for Complex Inflammatory Bowel Disease: Safety, Clinical and Steroid-Free Response

Objective Remission in patients with inflammatory bowel disease appears to plateau at 30–50% within the first year of biological monotherapy. Patients with Crohn’s disease (CD) and ulcerative colitis (UC) on monotherapy with biologics or small molecules may face this therapeutic ceiling, not reaching remission in relat...

A. Haase, J. Kelsen, J∅rgen Agnholt et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.